-

2 Day Drafting International Intellectual Property Agreements Training Course (February 6-7, 2023) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drafting International Intellectual Property Agreements Training Course" training has been added to ResearchAndMarkets.com's offering.

This practical course has been designed to focus on the drafting skills and legal and commercial issues to be considered when drawing up international IP agreements. If you are doing business in a complex multi-jurisdictional environment you need to know how to address difficult situations when designing and negotiating IP-related agreements in cross-border projects.

The world's national laws surrounding intellectual property have become more and more consistent over recent years but, whilst this is helpful to a large extent, it also sets the scene for numerous misunderstandings and disputes.

Learn about the different types of IP agreements and how to protect and exploit your rights to the best advantage for your business through carefully worded clauses. The use of practical exercises using example clauses will be worked through and discussed to embed and consolidate learning.

Key topics to be covered include:

  • The legal framework for international IP agreements
  • Dealing with patents, trademarks, trade secrets and domain names
  • The dangers and opportunities of IP agreement templates
  • Commercial expectations and industry sector differences
  • Key terms, choice of law and jurisdiction
  • Contentious IP contracts and dispute resolution
  • Forbidden clauses - competition law issues
  • Brexit-proofing your agreements

Why you should attend

  • Increase your knowledge of the legal and commercial issues surrounding international IP agreements
  • Improve your drafting skills by understanding the risks and opportunities
  • Benefit from an update on the laws affecting international IP agreements
  • Review competition law issues in relation to IP agreements
  • Understand the potential impact of Brexit on your IP agreements
  • Consolidate your learning with practical exercises on drafting clauses
  • Compare and discuss your experiences with other delegates and the expert faculty

Who Should Attend:

  • Patent attorneys
  • In-house lawyers
  • Legal executives
  • Commercial and contracts managers
  • Clinical and IP contract specialists
  • Product development managers
  • Research managers
  • Others who are involved in drafting or managing commercial IP agreements

Key Topics Covered:

Welcome and introduction to the course

General Aspects of IP Agreements

  • Types of IP
  • General drafting tips
  • Assignments vs licences

Types of licences

  • Non-Exclusive, Exclusive, Covenant not to Sue
  • Field of Use license, Cross license, Compulsory license
  • Sublicences, 'Have Made' right, Foundary Agreements

Elements of the agreement - part 1

  • Preamble
  • Recitals
  • Definitions

Elements of the agreement - part 2

  • Grant Clause
  • Reservations
  • Releases
  • Improvements

Practical exercise on drafting international IP agreements

Elements of the agreement - part 3

  • Financial Terms
  • Royalty Stacking
  • Reporting
  • Auditing

Elements of the agreement - part 4

  • Representations and Warranties
  • Assignment
  • Term & Termination
  • Choice of Law

Dispute resolution in agreements

  • Choice of Forum
  • Arbitration vs. Litigation
  • Arbitration Clauses
  • Other ADR (eg mediation, executive negotiation)

Practical exercise on drafting international IP agreements

For more information about this training visit https://www.researchandmarkets.com/r/jyenli.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

South Africa Manufacturing Industry Trends Report 2025: Focus on Food and Beverages, Metal, Petrochemical and Automotive Industries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Manufacturing Trends in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on trends in the manufacturing sector in South Africa, which is concentrated in the food and beverages, metal, petrochemical and automotive industries, provides information on the size and state of the manufacturing sector including contribution to GDP, performance, employment, production, profitability, trade, tariffs and fixed investment. Investing i...

United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and Sanofi - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Semaglutide Market is expected to expand from US$ 8.17 Billion in 2024 to US$ 17.29 Billion in 2033 at a Compound Annual Growth Rate (CAGR) of 8.68% during 2025-2033 The growth is fueled by rising awareness regarding obesity control, increasing incidence of diabetes,...

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...
Back to Newsroom